WASF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.250200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.175400E-01
Normal-vs-Stage2
2.311200E-01
Normal-vs-Stage3
2.921600E-01
Normal-vs-Stage4
6.783000E-01
Stage1-vs-Stage2
8.895000E-01
Stage1-vs-Stage3
6.275600E-01
Stage1-vs-Stage4
6.703400E-01
Stage2-vs-Stage3
5.535400E-01
Stage2-vs-Stage4
6.519600E-01
Stage3-vs-Stage4
5.241400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.361600E-01
Normal-vs-AfricanAmerican
2.533000E-01
Normal-vs-Asian
3.820600E-01
Caucasian-vs-AfricanAmerican
6.154600E-01
Caucasian-vs-Asian
8.033400E-01
AfricanAmerican-vs-Asian
7.828000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.987000E-01
Normal-vs-Female
2.452400E-01
Male-vs-Female
8.723600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.985800E-01
Normal-vs-Age(41-60Yrs)
7.446400E-01
Normal-vs-Age(61-80Yrs)
1.922000E-01
Normal-vs-Age(81-100Yrs)
1.551190E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.247800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.533200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.458800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.184800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.443800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.832600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.179000E-01
Normal-vs-Daily Drinker
1.100420E-01
Normal-vs-Weekly Drinker
7.164800E-01
Normal-vs-Occasional Drinker
5.243400E-01
Normal-vs-Social Drinker
6.411000E-01
Non Drinker-vs-Daily Drinker
9.449200E-01
Non Drinker-vs-Weekly Drinker
8.546100E-02
Non Drinker-vs-Occasional Drinker
4.420000E-01
Non Drinker-vs-Social Drinker
7.574500E-02
Daily Drinker-vs-Weekly Drinker
9.537600E-02
Daily Drinker-vs-Occasional Drinker
4.245000E-01
Daily Drinker-vs-Social Drinker
8.087900E-02
Weekly Drinker-vs-Occasional Drinker
5.692400E-01
Weekly Drinker-vs-Social Drinker
9.380000E-01
Occasional Drinker-vs-Social Drinker
5.886000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.618800E-01
Normal-vs-Grade 2
7.884000E-01
Normal-vs-Grade 3
7.673200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.800600E-01
Grade 1-vs-Grade 3
1.773620E-01
Grade 1-vs-Grade 4
8.618800E-01
Grade 2-vs-Grade 3
5.462600E-01
Grade 2-vs-Grade 4
7.884000E-01
Grade 3-vs-Grade 4
7.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.285600E-01
Normal-vs-NonDiabetic
2.993600E-01
Diabetic-vs-NonDiabetic
6.142400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.329200E-01
Normal-vs-NoPancreatitis
3.129000E-01
Pancreatitis-vs-NoPancreatitis
6.550200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.548400E-01
Normal-vs-N1
2.444600E-01
N0-vs-N1
6.796000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.300990E-01
Normal-vs-TP53-NonMutant
4.897800E-01
TP53-Mutant-vs-TP53-NonMutant
4.865800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
